MedicalResearch.com Interview with: [caption id="attachment_64133" align="alignleft" width="158"] Dr. Arscott[/caption] Karen Arscott, DO Department of Medical Education Geisinger Commonwealth School of Medicine Scranton PA 18509 MedicalResearch.com: What is the background for this study? Response: “Substance Use Disorder Risk Assessment (SUDRA)” is a proposed screening tool and possible source of prevention for substance use disorder (SUD) and alcohol use disorder (AUD).  The US opioid overdose epidemic continues to escalate with over one-hundred thousand deaths in a single year. The current screening tools used for assessing SUD identifies persons already suffering with advanced disease. Our investigation brings to light a simple screening tool which can be used to identify a person with “Preaddiciton” potential. For many years I have asked persons (both patients and nonpatients) the question how they felt the first time they took an opioid. Their answers have been astonishing. Probably the one answer that struck me the strongest was a professional colleague who answered that when she was prescribed Vicodin following a surgical procedure it made her feel so amazing that it scared her, and she never took another opioid. She reported to me that it would have been too easy to take regularly for the wonderful feeling – she however, recognized the danger of that feeling and avoided a potential substance use disorder. What if this risk was provided to all – what if parents and patients understood the risk if faced with that “feeling”? How many lives could be saved? We are very confident that these timely findings will be discussed and presented widely. The paper will be highly downloaded and cited by many interested in the prevention of substance use disorder – a new concept and much improved over the current treatment of advanced disease.